Methods, plasmid vectors and primers for assessing HIV viral fitness

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8673551
APP PUB NO 20100035229A1
SERIAL NO

12094708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods and means for the evaluation of HIV replicative capacity in a given environment. In particular, the invention provides a growth competition assay that can determine relative viral fitness using a recombinant tagged HIV-1 virus system. The methods rely on plasmid vectors, amplicons, primers and probes, and the generation of replication-competent viruses therefrom. Said methods and materials may find use in multiple fields including diagnostics, drug screening, pharmacogenetics and drug development.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN SCIENCES IRELAND UCCO CORK

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Baere Inky Paul Madeleine Temse, BE 2 2
De, Bethune Marie-Pierre T M M G Everberg, BE 12 11
Kraus, Guenter Sint-Katelijne-Waver, BE 11 7
Maes, Bart Anna Julien Rumst, BE 2 2
Mokany, Elisa Kirrawee, AU 13 100
Rimsky, Laurence Tatiana Kapellen, BE 2 4
Todd, Alison Velyian Glebe, AU 21 151

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00